(BRNL) Brunel International - Overview
Stock: Recruitment, Secondment, Project Management, Consultancy, Workforce
Dividends
| Dividend Yield | 6.24% |
| Yield on Cost 5y | 8.27% |
| Yield CAGR 5y | 16.36% |
| Payout Consistency | 78.8% |
| Payout Ratio | 55.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.9% |
| Relative Tail Risk | -11.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.57 |
| Alpha | -19.97 |
| Character TTM | |
|---|---|
| Beta | 0.116 |
| Beta Downside | 0.145 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.81% |
| CAGR/Max DD | -0.24 |
Description: BRNL Brunel International January 10, 2026
Brunel International N.V. (AS: BRNL) is a Dutch-based provider of integrated workforce and project-service solutions, operating across Europe, Australasia, the Middle East, India, the Americas and other regions. Its portfolio spans secondment, recruitment, and consultancy services, including project performance management, risk assurance, vendor inspection, commissioning, operational readiness, and full-service mobility (relocation, immigration, emergency repatriation, and logistics). The firm serves high-growth sectors such as life sciences, renewable and conventional energy, infrastructure, future mobility, and mining, and has been listed since its incorporation in 1975.
Key data points that shape Brunel’s outlook: (1) FY 2023 reported revenue of roughly €1.5 billion with an EBITDA margin near 6 %, reflecting modest profitability in a labor-intensive business; (2) Global renewable-energy capex reached about $1.5 trillion in 2023, driving demand for specialized project staffing where Brunel holds a competitive edge; (3) European labor-market tightness, especially in engineering and technical roles, is pushing up contract-rate pricing and creating tailwinds for recruitment-process-outsourcing (RPO) services. These drivers suggest that Brunel’s earnings are closely linked to macro-energy investment cycles and regional talent-supply constraints.
For a deeper dive into Brunel’s valuation metrics and scenario analysis, you might find ValueRay’s research platform a useful next step.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 45.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 24.15 > 1.0 |
| NWC/Revenue: 9.69% < 20% (prev 17.76%; Δ -8.06% < -1%) |
| CFO/TA 0.22 > 3% & CFO 118.3m > Net Income 45.9m |
| Net Debt (45.4m) to EBITDA (119.4m): 0.38 < 3 |
| Current Ratio: 2.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (50.5m) vs 12m ago 0.10% < -2% |
| Gross Margin: 39.05% > 18% (prev 0.55%; Δ 3850 % > 0.5%) |
| Asset Turnover: 461.1% > 50% (prev 262.5%; Δ 198.7% > 0%) |
| Interest Coverage Ratio: 5.72 > 6 (EBITDA TTM 119.4m / Interest Expense TTM 15.7m) |
Altman Z'' 4.87
| A: 0.47 (Total Current Assets 409.1m - Total Current Liabilities 150.9m) / Total Assets 544.1m |
| B: 0.00 (Retained Earnings 304.0k / Total Assets 544.1m) |
| C: 0.16 (EBIT TTM 90.1m / Avg Total Assets 577.7m) |
| D: 0.67 (Book Value of Equity 183.7m / Total Liabilities 274.1m) |
| Altman-Z'' Score: 4.87 = AA |
Beneish M -2.62
| DSRI: 0.57 (Receivables 310.7m/328.0m, Revenue 2.66b/1.60b) |
| GMI: 1.42 (GM 39.05% / 55.31%) |
| AQI: 1.09 (AQ_t 0.17 / AQ_t-1 0.16) |
| SGI: 1.66 (Revenue 2.66b / 1.60b) |
| TATA: -0.13 (NI 45.9m - CFO 118.3m) / TA 544.1m) |
| Beneish M-Score: -2.62 (Cap -4..+1) = A |
What is the price of BRNL shares?
Over the past week, the price has changed by +1.74%, over one month by -2.69%, over three months by -0.78% and over the past year by -13.90%.
Is BRNL a buy, sell or hold?
What are the forecasts/targets for the BRNL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.5 | 24.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 8 | 5.4% |
BRNL Fundamental Data Overview February 02, 2026
P/E Trailing = 24.9333
P/E Forward = 14.3062
P/S = 0.2927
P/B = 1.3877
P/EG = 1.99
Revenue TTM = 2.66b EUR
EBIT TTM = 90.1m EUR
EBITDA TTM = 119.4m EUR
Long Term Debt = 87.5m EUR (from longTermDebt, last quarter)
Short Term Debt = 24.4m EUR (from shortTermDebt, last quarter)
Debt = 120.8m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 45.4m EUR (from netDebt column, last quarter)
Enterprise Value = 421.9m EUR (376.5m + Debt 120.8m - CCE 75.4m)
Interest Coverage Ratio = 5.72 (Ebit TTM 90.1m / Interest Expense TTM 15.7m)
EV/FCF = 3.77x (Enterprise Value 421.9m / FCF TTM 112.0m)
FCF Yield = 26.55% (FCF TTM 112.0m / Enterprise Value 421.9m)
FCF Margin = 4.20% (FCF TTM 112.0m / Revenue TTM 2.66b)
Net Margin = 1.72% (Net Income TTM 45.9m / Revenue TTM 2.66b)
Gross Margin = 39.05% ((Revenue TTM 2.66b - Cost of Revenue TTM 1.62b) / Revenue TTM)
Gross Margin QoQ = 17.74% (prev 98.36%)
Tobins Q-Ratio = 0.78 (Enterprise Value 421.9m / Total Assets 544.1m)
Interest Expense / Debt = 3.07% (Interest Expense 3.70m / Debt 120.8m)
Taxrate = 31.69% (14.0m / 44.3m)
NOPAT = 61.5m (EBIT 90.1m * (1 - 31.69%))
Current Ratio = 2.71 (Total Current Assets 409.1m / Total Current Liabilities 150.9m)
Debt / Equity = 0.45 (Debt 120.8m / totalStockholderEquity, last quarter 269.9m)
Debt / EBITDA = 0.38 (Net Debt 45.4m / EBITDA 119.4m)
Debt / FCF = 0.41 (Net Debt 45.4m / FCF TTM 112.0m)
Total Stockholder Equity = 296.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.94% (Net Income 45.9m / Total Assets 544.1m)
RoE = 15.50% (Net Income TTM 45.9m / Total Stockholder Equity 296.0m)
RoCE = 23.50% (EBIT 90.1m / Capital Employed (Equity 296.0m + L.T.Debt 87.5m))
RoIC = 16.17% (NOPAT 61.5m / Invested Capital 380.7m)
WACC = 5.31% (E(376.5m)/V(497.3m) * Re(6.34%) + D(120.8m)/V(497.3m) * Rd(3.07%) * (1-Tc(0.32)))
Discount Rate = 6.34% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 81.65 | Cagr: 0.05%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈112.0m ; Y1≈138.2m ; Y5≈235.3m
Fair Price DCF = 135.2 (EV 6.85b - Net Debt 45.4m = Equity 6.81b / Shares 50.3m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -25.46 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: 48.05 | Revenue CAGR: 15.64% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=0.67 | Chg30d=+0.002 | Revisions Net=-2 | Growth EPS=+76.2% | Growth Revenue=+4.8%